Dr. Armando Heriazon, DVM, M.Sc, Ph.D is currently working as Adjacent Professor in University of Prince Edward Island (2010-Present). For the last three years, he has been working for Novartis Animal Health as Research Manager and Early Discovery & Technology Project Manager. (2010-2012). He completed his post doctoral fellow from University of Toronto, Ontario (2007-2007). He obtained his Ph.D from University of Guelph (2002-2007). He has specialized knowledge and experience in the field of animal and human immunology and in animal genetics. He also possesses advanced expertise in experimental design of basic and applied research, combined with a proven track record in scientific publications, presentations and lectures. He got many awards and recognitions in this field. While studying his Veterinary degree, he worked as a Veterinary assistant in private small animal hospitals and the Department of Ruminants and Equine Hospital of the Veterinary College. He also worked in sales, marketing and technical services departments for Merck, Sharp & Dohme and Pfizer. He has published Books, Research, Reviews and Proceedings in many international journals.
While studying his Veterinary degree, he worked as a Veterinary assistant in private small animal hospitals and the Department of Ruminants and Equine Hospital of the Veterinary College. During this time, he also worked as a teaching assistant of various courses including bovine and equine clinics. After obtaining his Doctorate in Veterinary Medicine, he worked as a Veterinary Physician of companion animals including dogs, cats and horses. Additionally, he worked as a Veterinarian of farm animals, particularly sheep and dairy and beef cattle. After some time in private practice, he joined the pharmaceutical industry and worked in sales, marketing and technical services for Merck, Sharp & Dohme and Pfizer.
Both his Masterís and PhD degrees gave him the opportunity to complete research in immunology, pathology, molecular and quantitative genetics. During his graduate studies, he investigated the immune responsiveness of dairy cows as a method to improve broad-based disease resistance. During his first post-doctoral fellowship, he investigated the immune-regulatory mechanisms involved in tolerance and inflammatory bowel disease (IBD). For the last three years he has been working for Novartis Animal Health as Research Manager and Early Discovery & Technology Project Manager. He served as Adjunct Professor at the Atlantic Veterinary College at the University of Prince Edward Island, where he have been part of research committees and have collaborated in diverse Masterís and Ph.D research projects.
Host-microbial or host-pathogen interactions at the gastrointestinal mucosa surface; Influence of the interactions between pathogen associated molecular patterns (PAMPs) and pattern recognition receptors (PRRs), in the development and modulation of immune responses by T cell subsets, to gastrointestinal Commensal Microbiota and pathogens.